diclofenac potassium + nimesulide
ApprovedWithdrawn 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Upper Respiratory Tract Infections
Conditions
Upper Respiratory Tract Infections
Trial Timeline
Apr 1, 2011 → —
NCT ID
NCT01257126About diclofenac potassium + nimesulide
diclofenac potassium + nimesulide is a approved stage product being developed by Novartis for Upper Respiratory Tract Infections. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT01257126. Target conditions include Upper Respiratory Tract Infections.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01257126 | Approved | Withdrawn |
Competing Products
20 competing products in Upper Respiratory Tract Infections